Alnylam Pharmaceuticals | ALNY - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Acadia Pharmaceuticals USD 8.33M 86K 2025-12
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Arrowhead Research USD 9.69M 637K 2025-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Incyte USD 33.69M 2.93M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 70M 3M 2025-12
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.74M 359K 2025-12
Takeda JPY 87.87B 43.48B 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03
Xencor USD 6.2M 338K 2025-12